Conservative treatment for patent ductus arteriosus in the preterm

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 92, Issue 4, 2007, Pages

  Vanhaesebrouck, Sophie ^a   Zonnenberg, Inge ^a   Vandervoort, Piet ^a   Bruneel, Els ^a   Van Hoestenberghe, Marie Rose ^a   Theyskens, Claire ^a  

^a DEPARTMENT OF CARDIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AIR CONDITIONING; ARTICLE; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; DIAGNOSTIC APPROACH ROUTE; ECHOCARDIOGRAPHY; FEMALE; HUMAN; INSPIRATORY CAPACITY; MALE; NEWBORN; PATENT DUCTUS ARTERIOSUS; POSITIVE END EXPIRATORY PRESSURE; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE INHIBITORS; DUCTUS ARTERIOSUS, PATENT; FEMALE; GESTATIONAL AGE; HUMANS; IBUPROFEN; INFANT CARE; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; POSITIVE-PRESSURE RESPIRATION; PROSPECTIVE STUDIES; PULMONARY SURFACTANTS; RETROSPECTIVE STUDIES;

EID: 34347357638     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/adc.2006.104596     Document Type: Article

References (26)

1. Van Overmeire B, Follens I, Hartman S, et al. Treatment of patent ductus arteriosus with ibuprofen. Arch Dis Child Fetal Neonatal Ed 1997;76:F179-84.
2. Wyllie J. Treatment of patent ductus arteriosus. Semin Neonatol 2003;8:425-32.
3. Malviya M, Ohlsson A, Shah S. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev 2003;3:CDO03951.
4. Floras M. Ibuprofen: alternative treatment for patent ductus arteriosus. Neonatal Netw 2003;22:27-31.
5. Knight DB. The treatment of patent ductus arteriosus in preterm infants. A review ana overview of randomized trials. Semin Neonatol 2001;6:63-73.
6. Gournay V, Roze JC, Kuster A, et al. Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial. Lancet 2004;364:1939-44.
7. Furzan JA, Reisch J, Tyson JE, et al. Incidence and risk factors for symptomatic patent ductus arteriosus among inborn very-low-birth-weight infants. Early Hum Dev 1985;12:39-48.
8. Mouzinho A, Rosenfeld CR, Risser R. Symptomatic patent ductus arteriosus in very-low-birth-weight infants: 1987-1989. Early Hum Dev 1991;27:65-77.
9. Koch J, Hensley GH, Roy L, et al. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics 2006;117:1113-21.
10. Hammerman C, Strates E, Valaitis S. The silent ductus: its precursors and its afterdeath. Pediatr Cardiol 1986;7:121-7.
11. Shah SS, Ohlsson A. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2003;2:CD004213.
12. Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2003;2:CD003481.
13. Koehne PS, Bein G, Alexi-Meskhishvilli V, et al. Patent ductus arteriosus in very low birthweight infants: complications of pharmacological and surgical treatment. J Perinat Med 2001;29:327-34.
14. Brooks JM, Travadi JN, Parole SK, et al. Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management. Arch Dis Child Fetal Neonatal Ed 2005;90:F190.
15. Fowlie PW, Davis PG. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev 2002;3:CD000174.
16. Van Overmeire B, Allegaert K, Casaer A, et al. Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 2004;364:1945-9.
17. Hammerman C, Kaplan M. Primum non nocere: prophylactic versus curative ibuprofen. Lancet 2004;364:1920-2.
18. Cooke L, Steer P, Woodgate P. Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev 2003;2:CD003745.
19. Vermont Oxford Network. http://www.vrtoxford.org.
20. Varvarigou A, Bardin CL, Beharry K, et al. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. JAMA 1996;275:539-44.
21. Mosca F, Bray M, Lattanzio M, et al. Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. J Pediatr 1997;131:549-54.
22. Pezzati M, Vangi V, Biagiotti R, et al. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr 1999;135:733-8.
23. Dani C, Bertini G, Reali M F, et al. Prophylaxis of patent ductus arteriosus with ibuprofen in preterm infants. Acta Paediatr 2000;89:1369-74.
24. Do Carolis MP, Romagnoli C, Polimeni V, et al. Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants. Eur J Pediatr 2000;159:364-8.
25. Patel J, Roberts I, Azzopardi D, et al. Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatr Res 2000;47:36-42.
26. Van Overmeire B, Smets K, Lecoutere D, et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med 2000;343:674-81.